Target intelligence / Profile preview

L-lysine (Lys)

Target
Lys
Molecular classification
Other
01

Overview

L-lysine is an essential alpha-amino acid that humans must obtain through diet to support protein biosynthesis and various metabolic functions [PubChem CID 5962]. It is a critical component for the structural integrity of connective tissues, as it is required for the cross-linking of collagen polypeptides through the action of lysyl oxidase [NIH MedlinePlus]. Additionally, lysine acts as a precursor to carnitine, facilitating the transport of long-chain fatty acids into the mitochondria for beta-oxidation and energy production [PubChem CID 5962]. Clinically, lysine is most notable for its role as a dietary supplement used to prevent or treat Herpes Simplex Virus (HSV) infections; its mechanism involves competing with arginine—a required nutrient for HSV replication—thereby potentially reducing viral load and outbreak frequency [StatPearls, PubMed PMID 664366]. While lysine is not a traditional therapeutic macromolecular target (such as an enzyme or GPCR), it is central to the pathology of metabolic conditions like hyperlysinemia and is investigated for its potential to improve calcium absorption and mitigate anxiety [National Organization for Rare Disorders, Mayo Clinic]. In pharmaceutical manufacturing, lysine is frequently utilized as a counter-ion to improve the solubility and pharmacokinetic profiles of various drug formulations, such as ibuprofen lysine [NCBI].

Other names
(S)-2,6-Diaminohexanoic acidKL-LysLysine
02

Mechanism of action

L-lysine acts as a competitive antagonist of L-arginine for cellular transport and incorporation into viral proteins, thereby inhibiting the replication of arginine-dependent viruses like Herpes Simplex Virus [StatPearls, PubMed PMID 664366]. It also serves as a fundamental substrate for protein synthesis, collagen cross-linking, and carnitine biosynthesis [PubChem CID 5962].

03

Biological functions

Immune responseOther
04

Disease associations

InfectionOther
05

Safety considerations

Gastrointestinal distress (nausea, diarrhea) at high supplemental doses [Mayo Clinic]Potential for renal toxicity or exacerbation of kidney disease with chronic high-dose intake [Mayo Clinic]Amino acid imbalance, particularly regarding the lysine-to-arginine ratio [PubMed PMID 664366]
06

Biomarkers

Plasma lysine concentration [National Organization for Rare Disorders]Urinary lysine excretion [National Organization for Rare Disorders]Plasma lysine-to-arginine ratio [PubMed PMID 664366]

Beyond the preview

Go deeper on L-lysine (Lys).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on L-lysine (Lys).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call